Published in Eur J Immunol on August 01, 1972
Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption. J Exp Med (1973) 1.42
The Fas death factor. Science (1995) 13.81
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell (1993) 9.06
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 7.34
A new member of the immunoglobulin superfamily--CTLA-4. Nature (1987) 5.10
Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (1985) 5.06
Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide. Cell Immunol (1971) 4.69
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med (1993) 4.53
Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med (1992) 3.86
CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol (1993) 3.74
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Evidence for a small pool of immunocompetent cells in the mouse thymus. Exp Cell Res (1969) 3.17
Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells. J Exp Med (1972) 3.00
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol (1991) 2.92
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ (2005) 2.91
Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol (1982) 2.47
Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol (1988) 2.45
Characteristics of the immunocompetent cells in the mouse thymus: cell population changes during cortisone-induced atrophy and subsequent regeneration. Cell Immunol (1970) 2.44
Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med (1985) 2.18
Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr Biol (1999) 2.11
Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes. J Exp Med (1971) 2.09
Evidence for a small pool of immunocompetent cells in the mouse thymus. Its role in the humoral antibody response against sheep erythrocytes, bovine serum albumin, ovalbumin and the NIP determinant. Cell Immunol (1970) 2.00
In vitro stimulation of mouse thymus cells by PHA and allogeneic cells. Cell Immunol (1971) 1.94
Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol (1994) 1.89
Programmed cell death in Dictyostelium. J Cell Sci (1994) 1.73
TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med (1995) 1.64
Further evidence for autonomy of T cells mediating specific in vitro cytotoxicity: efficiency of very small amounts of highly purified T cells. Cell Immunol (1973) 1.64
The inducible cytotoxic T-lymphocyte-associated gene transcript CTLA-1 sequence and gene localization to mouse chromosome 14. Nature (1986) 1.61
Mechanism of T-cell-mediated cytolysis: the lethal hit stage. Contemp Top Immunobiol (1977) 1.61
Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur J Immunol (1994) 1.58
Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. Clin Exp Immunol (1975) 1.44
T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol (1994) 1.40
Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int J Cancer (1978) 1.33
The lethal hit stage of mouse T and non-T cell-mediated cytolysis: differences in cation requirements and characterization of an analytical "cation pulse" method. Eur J Immunol (1976) 1.26
Evidence for thymic dependence of PHA-reactive cells in spleen and lymph nodes and independence in bone marrow. J Immunol (1971) 1.25
Role of B cells in the expression of the PPD response of human lymphocytes in vitro. Scand J Immunol (1975) 1.24
Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin. J Exp Med (1984) 1.23
The effect of irradiation on T-cell suppression of ELISA-determined Ig production by human blood B-cells in vitro. Clin Exp Immunol (1979) 1.22
T-cell response to polyvinyl pyrrolidone is linked to maturity of B cells. Nature (1975) 1.19
Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies. Immunol Rev (1982) 1.18
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol (2008) 1.17
Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur J Immunol (1989) 1.15
Functional fractionation of human cytotoxic cells using differences in their cation requirements. Nature (1975) 1.15
LFA-1 but not Lyt-2 is associated with killing activity of cytotoxic T lymphocyte hybridomas. Nature (1982) 1.15
A differential molecular biology search for genes preferentially expressed in functional T lymphocytes: the CTLA genes. Immunol Rev (1988) 1.13
Specific cytotoxicity by sensitized mouse thymus cells on tissue culture target cells. Cell Immunol (1970) 1.12
Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon. Int J Cancer (1980) 1.11
The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity. J Exp Med (1995) 1.11
Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells). Cell Immunol (1974) 1.10
Homology between reaper and the cell death domains of Fas and TNFR1. Cell (1995) 1.10
Effect of human leukocyte interferon on the response of lymphocytes to mitogenic stimuli in vitro. Scand J Immunol (1974) 1.10
Apparent caspase independence of programmed cell death in Dictyostelium. Curr Biol (1998) 1.09
Characterization of an Lyt-1+ cytolytic T-cell clone specific for a polymorphic domain of the I-Ak molecule. Scand J Immunol (1982) 1.06
Immunosuppression in irradiated breast cancer patients: in vitro effect of cyclooxygenase inhibitors. Bull N Y Acad Med (1989) 1.06
A necrotic cell death model in a protist. Cell Death Differ (2006) 1.05
Sensitivity of different target cells to the killing action of peripheral lymphocytes stimulated by autologous lymphoblastoid cell lines. Int J Cancer (1974) 1.05
On the specificity of cell-mediated cytotoxicity in vitro. Cell Immunol (1970) 1.05
Blood lymphocyte subpopulations in breast cancer patients following radiotherapy. Clin Exp Immunol (1977) 1.05
Fas and other cell death signaling pathways. Semin Immunol (1997) 1.04
Sensitivity of cytotoxic T cells to T-cell mediated cytotoxicity. Nature (1974) 1.04
More than one way to go. Proc Natl Acad Sci U S A (2001) 1.04
Self-sparing of long-term in vitro-cloned or uncloned cytotoxic T lymphocytes. J Exp Med (1986) 1.04
CTLA-1 and CTLA-3 serine esterase transcripts are detected mostly in cytotoxic T cells, but not only and not always. J Immunol (1987) 1.03
Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg (1998) 1.03
Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Clin Cancer Res (2000) 1.03
Expression of human class I histocompatibility antigens at the surface of DNA-transformed mouse L cells. Immunogenetics (1982) 1.03
Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol (1994) 1.02
Uptake of adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas. Acta Neurochir (Wien) (1990) 1.02
Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+. Immunology (1980) 1.01
Studies on the proliferation of thymus cells injected into syngeneic or allogeneic irradiated mice. Clin Exp Immunol (1971) 1.00
Divalent cation requirements as a tool for the study of cell-mediated cytotoxocity systems. Adv Exp Med Biol (1976) 1.00
Specific cytotoxicity of H-2-incompatible mouse lymphocytes following mixed culture in vitro. Transplantation (1970) 0.99
Cytotoxic immune cells with specificity for defined soluble antigens. II. Chasing the killing cells. Cell Immunol (1973) 0.98
An insertional mutagenesis approach to Dictyostelium cell death. Cell Death Differ (1998) 0.98
Requirement for hexose, unrelated to energy provision, in T-cell-mediated cytolysis at the lethal hit stage. J Exp Med (1978) 0.97
Interferon therapy in Hodgkin's disease. A case report. Acta Med Scand (1976) 0.96
Steroid sensitivity of the PHA and PWM responses of fractionated human lymphocytes in vitro. Exp Cell Res (1976) 0.95
Target cell recognition by cytolytic T cells: different requirements for the formation of strong conjugates or for proceeding to lysis. J Immunol (1979) 0.95
Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res (2000) 0.94
Cellular reactions against Burkitt lymphoma cells. 3. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells. Int J Cancer (1972) 0.94
Mouse T cell-mediated cytolysis specifically triggered by cytophilic xenogeneic serum determinants: a caveat for the interpretation of experiments done under "syngeneic" conditions. J Immunol (1978) 0.94
Studies on the recirculating cells in the mouse thymus. Cell Immunol (1972) 0.94
T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia. J Exp Med (1978) 0.94
Synergism between thymocytes and lymph node cells in the graft-verses-host response effect of cortisone treatment of the thymus cell donor. J Immunol (1973) 0.94
Lymphocyte activation and effector functions. Editorial overview. The role of cell surface molecules. Curr Opin Immunol (1993) 0.94
Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains. J Immunol (1983) 0.93
Sensitivity of H-2-less target cells and role of H-2 in T-cell-mediated cytolysis. Nature (1976) 0.93
Impact of fractionation procedures on lymphocyte activities in vitro and in vivo. Separation of cells with high concentrations of surface immunoglobin. Transplant Proc (1972) 0.93
T cell-mediated cytolysis: on the strength of effector-target cell interaction. Eur J Immunol (1983) 0.93
Evidence for a loss of recirculating capacity of T-cells after antigenic stimulation. Clin Exp Immunol (1973) 0.92
Disappearance of specifically mlc-responsive lymphocytes in cba mice injected with cells from the h-2-compatible, m-antigen-incompatible strain c3h. Scand J Immunol (1975) 0.92
Blood lymphocytes after radiation therapy of mammary carcinoma. Acta Radiol Ther Phys Biol (1974) 0.92
Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsiveness. Scand J Haematol (1984) 0.92
Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytes. Acta Med Scand (1979) 0.90
T lymphocyte subpopulations in blood following radiation therapy for breast cancer. Eur J Cancer Clin Oncol (1982) 0.90